Maryland Firm's Drug Cures Neuropathy In Diabetic Mice In Michigan TestRegeneRx Biopharmaceuticals Inc. (OTC Bulletin Board: RGRX) reported Wednesday that in a Michigan trial, researchers found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice.
UM: Too Many Neuropathy Patients Get High-Cost, Low-Yield TestsResearchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.

More From CBS Detroit

Hump Day Drinks: 8 Cheery Cocktail RecipesNow that you've made it through half the work week, it's time to celebrate!
Daily J

Watch & Listen